Find investors
← Back to all investors
David Grecsek
ResearchedAngel Investors

David Grecsek

Director of Investment Research

Angel InvestorsSeed Round
Pitch David

Get their honest, personalized take on your startup.

Sign in to pitch David

At a glance

Full Name
David (Dave) Grecsek, CFA, CAIA
Title
Managing Director, Investment Strategy & Research; Partner
Firm
Aspiriant
Firm Type
Independent, fee-only wealth management firm (Registered Investment Adviser) — *not* an angel-investor or venture firm (the stub's "Angel Investors / Seed Round" classification is inaccurate)
Investment Stage
N/A — Aspiriant is a multi-asset-class wealth manager that allocates client capital across public equities, fixed income, and alternatives (real estate, hedge funds, private managers), not a startup-stage investor
Check Size
Not applicable/disclosed (firm manages client portfolios, not direct startup checks)
Target Company Profile
Not applicable — David's work is manager selection, asset allocation, and due diligence rather than direct company investing
Sector Focus
Broad multi-asset: global equities, fixed income, and alternative investments (real estate, hedge funds/absolute-return strategies)
Geographic Focus
United States / global markets (based in New York)
Location
New York, NY (resides in Brielle, NJ)

Background

David Grecsek is a Managing Director in Investment Strategy & Research and a Partner at Aspiriant, an independent wealth management firm, working out of the firm's New York office. He has specialized in private client investment management since 1994. At Aspiriant he leads asset allocation, investment due diligence, and portfolio construction, sits on the firm's Investment Committee, and heads several investment subcommittees. He is also one of the firm's most public voices, regularly communicating strategy to advisors, clients, and the media, and has been quoted in outlets such as The New York Times and The Wall Street Journal.

Before Aspiriant, David was a Senior Analyst at Deloitte Investment Advisors starting in 2003, focused on multi-asset manager selection across separate accounts, mutual funds, and alternative investments. In 2004 he became Head of Investment Research there, reporting to the Investment Policy Committee on capital market expectations, strategic and tactical asset allocation, and tax-efficient manager sourcing for more than $3 billion in client assets. Earlier, he spent eight years at Merrill Lynch & Co., supporting one of the industry's largest managed-account platforms through various investment research and risk-management roles.

David holds an MBA in Finance from the Graduate School of Management at Rutgers University and a BA in Liberal Arts from The College of New Jersey. He earned both the Chartered Financial Analyst (CFA) and Chartered Alternative Investment Analyst (CAIA) designations, and is an active member of the CFA Institute, the CAIA Association, and the New York Society of Security Analysts (NYSSA), where he has served on the Private Wealth Management and Alternative Investment committees.

Investment Thesis & Focus

  • Works as a top-down allocator and manager-selector, not a direct company or startup investor — his mandate is asset allocation, due diligence, and portfolio construction for private-client capital.
  • Strong advocate for alternative investments as portfolio diversifiers when traditional markets falter; he has argued that "investors have to move away from traditional stocks and bonds when neither is working," pointing to real estate, alternatives, and hedge funds using absolute-return strategies.
  • Emphasizes capital-market expectations and tax-efficient implementation across strategic and tactical asset allocation — a discipline he has carried from his Deloitte Investment Advisors and Merrill Lynch research roles.
  • Recent house/team views he helps shape stress AI-driven innovation, monetary-policy shifts, trade dynamics, and geopolitical risk as the dominant forces shaping market opportunities and risks.

Notable Investments

  • No verifiable record of individual angel or venture investments exists — David's role at Aspiriant is institutional asset allocation and third-party manager due diligence, not direct startup/company investing. Rather than fabricate a portfolio, this section is left with that clarification.
  • His investable focus areas at the firm include diversified allocations to public equities, fixed income, real estate, hedge funds, and other alternative/absolute-return managers selected through the firm's due-diligence process.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.